The mortality risk of overhydration in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 24, Issue 5, 2009, Pages 1574-1579

  Wizemann, Volker ^a   Wabel, Peter ^a,c   Chamney, Paul ^a   Zaluska, Wojciech ^b   Moissl, Ulrich ^a   Rode, Christiane ^a   Malecka Masalska, Teresa ^b   Marcelli, Daniele ^a  

^a Georg Haas Dialysezentrum Giessen ^*  (Germany)

^b University of Lublin   (Poland)

^c Daimlerstrasse 15   (Germany)

Author keywords

Bioimpedance; Fluid status; Haemodialysis; Mortality; Overhydration

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY COMPOSITION; DIABETES MELLITUS; EXTRACELLULAR FLUID; FOLLOW UP; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MONITOR; MORTALITY; OVERHYDRATION; PERIPHERAL VASCULAR DISEASE; PHYSICAL DISEASE BY COMPOSITION OF BODY FLUIDS, EXCRETA AND SECRETIONS; PREDICTION; PRIORITY JOURNAL; REHYDRATION; SURVIVAL TIME; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; BODY COMPOSITION; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY DISEASES; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; WATER-ELECTROLYTE IMBALANCE;

EID: 65249173419     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn707     Document Type: Article

References (46)

1. Wystrychowski G, Levin NW. Dry weight: sine qua non of adequate dialysis. Adv Chronic Kidney Dis 2007; 14: e10-e16
2. Charra B. 'Dry weight' in dialysis: the history of a concept. Nephrol Dial Transplant 1998; 7: 1882-1885
3. Wizemann V, Schilling M. Dilemma of assessing volume state-the use and limitations of a clinical score. Nephrol Dial Transplant 1995; 10: 2114-2117
4. Wizemann V, Leibinger A, Mueller K et al. Influence of hydration state on plasma volume changes during ultrafiltration. Artif Organs 1995; 19: 416-419
5. Scribner BH, Buri R, Caner JE et al. The treatment of chronic uremia by means of intermittent hemodialysis: a preliminary report. 1960 [classical article]. J Am Soc Nephrol 1998; 9: 719-726
6. Levin NW, Zhu F, Keen M. Interdialytic weight gain and dry weight. Blood Purif 2001; 19: 217-221
7. Jaeger JQ, Mehta RL. Assessment of dry weight in hemodialysis: an overview. J Am Soc Nephrol 1999; 10: 392-403
8. Saran R, Bragg-Gresham JL, Levin NW et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 2006; 69: 1222-1228
9. Movilli E, Gaggia P, Zubani R et al. Association between high ultra-filtration rates and mortality in uraemic patients on regular haemodial-ysis. A 5-year prospective observational multicentre study. Nephrol Dial Transplant 2007; 22: 3547-3552
10. Ozkahya M, Ok E, Toz H et al. Long-term survival rates in haemodial-ysis patients treated with strict volume control. Nephrol Dial Transplant 2006; 21: 3506-3513
11. Charra B, Calemard E, Cuche M et al. Control of hypertension and prolonged survival on maintenance hemodialysis. Nephron 1983; 33: 96-99
12. Charra B, Calemard E, Ruffet M et al. Survival as an index of adequacy of dialysis. Kidney Int 1992; 41: 1286-1291
13. Charra B, Calemard M, Laurent G. Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 1996; 16: 35-44
14. Kouw PM, Kooman JP, Cheriex EC et al. Assessment of postdialysis dry weight: a comparison of techniques. J Am Soc Nephrol 1993; 4: 98-104
15. Leunissen KML, Kouw PM, Kooman JP et al. New techniques to determine fluid status in hemodialysed patients. Kidney Int 1993; 43: 50-56
16. Charra B. Fluid balance, dry weight, and blood pressure in dialysis. Hemodial Int 2007; 11: 21-31
17. Moissl UM, Wabel P, Chamney PW et al. Body fluid volume determination via body composition spectroscopy in health and disease. Physiol Meas 2006; 27: 921-933
18. Moissl U, Bosaeus I, Lemmey A et al. Validation of a 3C model for determination of body fat mass. J Am Soc Nephrol 2007; 18 A: 257
19. Moissl U, Wabel P, Chamney PW et al. Validation of a bioimpedance spectroscopy; method for the assessment of fat free mass. NDT Plus 2008; 1(Suppl 2): ii215
20. Kraemer M, Rode C, Wizemann V. Detection limit of methods to assess fluid status changes in dialysis patients. Kidney Int 2006; 69: 1609-1620
21. Chamney PW, Kraemer M, Rode C et al. A new technique for establishing dry weight in hemodialysis patients via whole body bioimpedance. Kidney Int 2002; 61: 2250-2258
22. Passauer J, Miller H, Schleser A et al. Evaluation of clinical dry weight assessment in haemodialysis patients by bioimpedance-spectroscopy. J Am Soc Nephrol 2007; 18 A: 256
23. Machek P, Jirka T, Moissl U et al. Optimal fluid status assessed with bioimpedance spectroscopy reduces Imes and hospitalisation in hemodialysis patients. NDT Plus 2008; 1(Suppl 2): ii322-ii322
24. Wabel P, Rode C, Moissl U et al. Accuracy of bioimpedance spectroscopy (BIS) to detect fluid status changes in hemodialysis patients. Nephrol Dial Transplant 2007 22(Suppl 6): VI 129
25. Chamney PW, Wabel P, Moissl UM et al. A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr 2007; 85: 80-89
26. Wabel P, Moissl U,Chamney P et al.Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant 2008; 9: 2965-2971
27. Wieskotten S, Heinke S, Wabel P et al. Bioimpedance-based identification of malnutrition using fuzzy logic. Physiol Meas 2008; 29: 639-654
28. Wabel P, Chamney PW, Moissl U et al. Reproducibility of bioimpedance spectroscopy (BIS) for the assessment of body composition and dry weight. J Am Soc Nephrol 2007; 18 A: 255
29. Agarwal R. Assessment of blood pressure in hemodialysis patients. Semin Dial 2002; 15: 299-304
30. Locatelli F, Marcelli D, Conte F et al. Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease. J Am Soc Nephrol 2001; 12: 2411-2417
31. Rabbat CG, Thorpe KE, Russell JD et al. Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada. J Am Soc Nephrol 2000; 11: 917-922
32. Elinder CG, Jones E, Briggs JD et al. Improved survival in renal replacement therapy in Europe between 1975 and 1992: an ERA-EDTA Registry study. Nephrol Dial Transplant 1999; 14: 2351-2356
33. Pierratos A. Daily nocturnal home hemodialysis. Kidney Int 2004; 65: 1975-1986
34. Pifer TB, Mccullough KP, Port FK et al. Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int 2002; 62: 2238-2245
35. Kaysen GA, Dubin JA, Muller HG et al. Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int 2002; 61: 2240-2249
36. Kaysen G, Stevenson FT, Depner TA. Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 1997; 5 658-668
37. Stenvinkel P, Heimburger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis inchronic renal failure. Kidney Int 1999; 55: 1899-1911
38. Beddhu S, Allen-Brady K, Cheung AK et al. Impact of renal failure on the risk of myocardial infarction and death. Kidney Int 2002; 62: 1776-1783
39. Joki N, Hase H, Tanaka Y et al. Relationship between serum albumin level before initiating haemodialysis and angiographic severity of coronary atherosclerosis in end-stage renal disease patients. Nephrol Dial Transplant 2006; 21: 1633-1639
40. Bammens B, Evenepoel P, Keuleers H et al. Free serumconcentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 2006; 69: 1081-1087
41. Kakiya R, Shoji T, Tsujimoto Y et al. Body fat mass and lean mass as predictors of survival in hemodialysis patients. Kidney Int 2006; 70: 549-556
42. Chamney PW, Moissl U, Wabel P et al. New device overcomes the problem of erroneous measurement of fat free mass in patients with renal failure. J Am Soc Nephrol 2007; 18 A: 453
43. Szczech LA, Reddan DN, Klassen PS et al. Interactions between dialysis-related volume exposures, nutritional surrogates and mortality among ESRD patients. Nephrol Dial Transplant 2003; 18: 1585- 1591
44. Saran R, Bragg-Gresham JL, Levin NW et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 2006; 69: 1222-1228
45. Kimmel PL, Varela MP, Peterson RA et al. Interdialytic weight gain and survival in hemodialysis patients: effects of duration of ESRD and diabetes mellitus. Kidney Int 2000; 57: 1141-1151
46. Lopez-Gomez JM, Villaverde M, Jofre R et al. Interdialytic weight gain as a marker of blood pressure, nutrition, and survival in hemodialysis patients. Kidney Int 2005; 93(Suppl): S63-S68